
    
      To study the pharmacokinetic and pharmacodynamic profile of a new human insulin (Jusline)
      after subcutaneous administration in the abdominal, and to compare this profile with Humulin
      insulin for three different preparations (Regular, NPH, and Premixed Regular/NPH (30/70)).
    
  